Accelerating Discovery to Clinic
Paul Dabrowski
Tuesday, September 13, 2022
Tweet
Transcript
Embed
Email
Bookmark
<<
<
>
>>
Tweet
Facebook
Email
Chapters
Introduction
Why?
What stands in the way of accessible engineered biological therapies?
Mission-Driven
Synthego was founded to revolutionize genome engineering technology
Moving CRISPR forward: synthetic single guide RNA
CRISPRevolution sgRNA and multi-guide set the standard
1 million guides synthesized power the revolution
Helping translate genomics into the clinic
30,000 engineered cell edits discover and validate targets
1,000 publications show path for new medicines
Synthego platform capabilities enable rapid R&D
Ultimately making engineered biological therapies accessible to all patients
Synthego empowers clinical research organizations with GMP CRISPR
Operational full stack technology de-risks translational biology rapidly
Next-Gen GMP Manufacturing
Synthego Enabling the Future of Cell & Gene Therapies with Industrialized CRISPR Platforms
No transcript for this webinar
More Info
Request info